TREATMENT OF NOCTURNAL ASTHMA WITH PULSED-RELEASE ALBUTEROL

被引：14

作者：

BOGIN, RM

BALLARD, RD

机构：

[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262

[2] VET ADM MED CTR,DEPT MED,DENVER,CO 80220

来源：

CHEST | 1992年 / 102卷 / 02期

关键词：

D O I：

10.1378/chest.102.2.362

中图分类号：

R4 [临床医学];

学科分类号：

1002 [临床医学]; 100602 [中西医结合临床];

摘要：

The treatment of nocturnal asthma remains a challenge. We investigated the use of a pulsed-released albuterol in ten patients with nocturnal symptoms of asthma. In a randomized, double-blind, placebo-controlled, crossover designed study, we tested the use of 8 mg of pulsed-release albuterol sulfate (Proventil Repetabs) vs placebo. The pulsed-release albuterol significantly blunted the overnight drop in FEV1, improved peak flow readings in the morning, and decreased subjective awakenings from sleep. We conclude that pulsed-released albuterol is an effective therapeutic option in patients with nocturnal asthma.

引用

页码：362 / 366

页数：5

共 24 条

[1]

ARKINSTALL WW, 1987, AM REV RESPIR DIS, V135, P316

[2]

BAGG LR, 1980, EUR J RESPIR DIS, V61, P298

[3]

KETOTIFEN AND NOCTURNAL ASTHMA [J].